Q1 EPS Estimates for Legend Biotech Reduced by William Blair
Analysts at William Blair lowered their Q1 2025 earnings estimates for Legend Biotech in a research report issued to clients ...
William Blair Has Optimistic Outlook of NKTR Q1 Earnings
Analysts at William Blair raised their Q1 2025 EPS estimates for Nektar Therapeutics in a research report issued to clients and investors on Thursday, March 13th. William Blair analyst A. Hsieh now ...